top of page
Danube Labs Call for Proposals - September 2023
Your research project translated into the medicines of tomorrow

CEBINA has partnered with Evotec, the industry-leading drug discovery and development company, to create Danube Labs, an initiative to accelerate academic research projects for new therapeutics to mature into projects ready for spin-out company formation, or out-licensing.

Picture_DL Call 09 23_edited.jpg


Innovative drug discovery projects from Universities and Research Institutes in Central and Eastern Europe

(stage of development: at least in vitro PoC, ideally in vivo PoC)

Projects with significant commercial potential and unmet medical need​

Intellectual Property

(either filed patents or potential for new IP)​

Collaborative team spirit​


Danube Labs is a partnership between:

Evotec_white transparent.png
CBC logo white.png

We provide funding to bridge the gap between academia and industry, translating academic research projects into focused drug discovery programs


  • Submit a 1-3 page overview of your project to us 

  • We will evaluate your project and for selected projects work with you to create a detailed acceleration project proposal

  • Project proposals will be reviewed by our Joint Steering Committee for Danube Labs awards (ca. 500k€ + 500k€ in kind)

  • For awarded projects research work will be carried out by you, Evotec and CEBINA to reach the planned milestones within 6 to 9 months

  • Projects that meet the defined milestones and success criteria will be commercialized either through spin-out company formation or out-licencing

Download the application form on the Danube Labs website and submit it to by the 6th October 2023

For more information and the opportunity to ask questions to the Danube labs team, join our upcoming webinars:

Learn more about Danube Labs at:

For any further inquiry, contact us at

bottom of page